Core Insights - The stock of Jianerkang experienced a decline of 0.85% on November 18, with a trading volume of 28.09 million yuan [1] - The company reported a net financing outflow of 1.45 million yuan on the same day, indicating a low financing balance compared to historical levels [1] - Jianerkang's main business includes the development, production, and sales of disposable medical devices and disinfectant hygiene products, with a revenue composition heavily weighted towards nursing products and surgical consumables [1] Financing and Trading Data - On November 18, Jianerkang had a financing buy-in amount of 1.76 million yuan, with a total financing balance of 65.11 million yuan, representing 5.60% of its market capitalization [1] - The financing balance is below the 30th percentile of the past year, indicating a low level of financing activity [1] - No shares were sold or repaid in the securities lending market on the same day, with a remaining balance of 100 shares valued at 2,814 yuan, which is above the 70th percentile of the past year [1] Financial Performance - For the period from January to September 2025, Jianerkang reported a revenue of 725 million yuan, a year-on-year decrease of 7.35%, and a net profit attributable to shareholders of 76.41 million yuan, down 18.24% year-on-year [2] - The number of shareholders decreased by 6.15% to 17,100, while the average number of circulating shares per person increased by 38.51% to 2,286 shares [2] Shareholder and Dividend Information - Since its A-share listing, Jianerkang has distributed a total of 42.12 million yuan in dividends [3] - As of September 30, 2025, the largest circulating shareholder is the Medical Device ETF (159883), which holds 285,100 shares as a new shareholder [3]
健尔康11月18日获融资买入176.25万元，融资余额6510.76万元